Sanofi Long-Term Concentrated

Location: Paris, France

CIK: 0001121404 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 11, 2026

Total Value: $310M (100.0% shares, 0.0% debt)

Holdings (8)

MGTX MeiraGTx Holdings plc 31.2%

Value $96.97M Shares 12,197,737 Est. Cost $5.86 Unrealized +41.8%

INBX Inhibrx Biosciences, Inc. 29.5%

Value $91.48M Shares 1,157,926 Est. Cost $15.23 Unrealized +347.3%

NVAX Novavax 14.9%

Value $46.24M Shares 6,880,481 Est. Cost $9.64 Unrealized -21.8%

ANAB AnaptysBio 12.8%

Value $39.85M Shares 821,917 Est. Cost $24.22 Unrealized +60.9%

IMRX Immuneering Corp 5.7%

Value $17.82M Shares 2,708,559 Est. Cost $5.19 Unrealized +23.7%

MPLT MapLight Therapeutics Inc. 5.2%

Value $16.02M Shares 912,041 Est. Cost $16.75 Unrealized 0.0%

ELDN Eledon 0.4%

Value $1.231M Shares 814,980 Est. Cost $3.94 Unrealized -39.7%

QTTB Q32 Bio Inc. 0.3%

Value $810K Shares 244,083 Est. Cost $31.58 Unrealized -91.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$96.97M	31.2%	$5.86	+41.8%	COM	G59665102
INBX	Inhibrx Biosciences, Inc.	1,157,926	$91.48M	29.5%	$15.23	+347.3%	COM	45720N103
NVAX	Novavax	6,880,481	$46.24M	14.9%	$9.64	-21.8%	COM NEW	670002401
ANAB	AnaptysBio	821,917	$39.85M	12.8%	$24.22	+60.9%	COM	032724106
IMRX	Immuneering Corp	2,708,559	$17.82M	5.7%	$5.19	+23.7%	CLASS A COM	45254E107
MPLT	MapLight Therapeutics Inc.	912,041	$16.02M	5.2%	$16.75	0.0%	COM	56565P103
ELDN	Eledon	814,980	$1.231M	0.4%	$3.94	-39.7%	COM	28617K101
QTTB	Q32 Bio Inc.	244,083	$810K	0.3%	$31.58	-91.0%	COM	746964105